|
Eine Ebene nach oben |
Gruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 3
Zeitschriftenartikel
Brown, Jennifer R.; Moslehi, Javid; O'Brien, Susan; Ghia, Paolo; Hillmen, Peter; Cymbalista, Florence; Shanafelt, Tait D.; Fraser, Graeme; Rule, Simon; Kipps, Thomas J.; Coutre, Steven; Dilhuydy, Marie-Sarah; Cramer, Paula; Tedeschi, Alessandra; Jäger, Ulrich; Dreyling, Martin; Byrd, John C.; Howes, Angela; Todd, Michael; Vermeulen, Jessica; James, Danelle F.; Clow, Fong; Styles, Lori; Valentino, Rudy; Wildgust, Mark; Mahler, Michelle und Burger, Jan A.
(2017):
Characterization of atrial fibrillation adverse events reported in ibrutinib randomized controlled registration trials.
In: Haematologica, Bd. 102, Nr. 10: S. 1796-1805
Fischer, Kirsten; Al-Sawaf, Othman; Fink, Anna-Maria; Dixon, Mark; Bahlo, Jasmin; Warburton, Simon; Kipps, Thomas J.; Weinkove, Robert; Robinson, Sue; Seiler, Till; Opat, Stephen; Owen, Carolyn; Lopez, Javier; Humphrey, Kathryn; Humerickhouse, Rod; Tausch, Eugen; Frenzel, Lukas; Eichhorst, Barbara; Wendtner, Clemens-M.; Stilgenbauer, Stephan; Langerak, Anton W.; Dongen, Jacque J. M. van; Böttcher, Sebastian; Ritgen, Matthias; Göde, Valentin; Mobasher, Mehrdad und Hallek, Michael
(2017):
Venetoclax and obinutuzumab in chronic lymphocytic leukemia.
In: Blood, Bd. 129, Nr. 19: S. 2702-2705
Wendtner, Clemens M.; Hallek, Michael; Fraser, Graeme A. M.; Michallet, Anne-Sophie; Hillmen, Peter; Dürig, Jan; Kalaycio, Matt; Gribben, John G.; Stilgenbauer, Stephan; Buhler, Andreas; Kipps, Thomas J.; Purse, Brendan; Zhang, Jennie; De Bedout, Sabine; Mei, Jay und Chanan-Khan, Asher
(2016):
Safety and efficacy of different lenalidomide starting doses in patients with relapsed or refractory chronic lymphocytic leukemia: results of an international multicenter double-blinded randomized phase II trial*.
In: Leukemia & Lymphoma, Bd. 57, Nr. 6: S. 1291-1299